SUBSCRIBE
SUBSCRIBE
News   Drug Development

ReNeuron Reports Encouraging Signs From Parkinson’s Disease Programme

February 16, 2006 | 
1 min read

ReNeuron Group PLC said the stem cells it is working on to find a treatment for Parkinson’s disease have shown attributes that could be used to reverse the effects of the illness.

Preclinical Europe
MORE ON THIS TOPIC
Cardiovascular disease
Merck’s Winrevair Cuts Morbidity, Mortality Risk by Over 75% in Phase III PAH Study
April 1, 2025
 · 
2 min read
 · 
Tristan Manalac
Climb up, hand help businessman build ladder
Diabetes
Vertex Cuts Diabetes Asset, but Analysts Keen on Phase III Option
March 31, 2025
 · 
4 min read
 · 
Annalee Armstrong
World heart day. Sketch style human heart. Retro halftone hands reaching out to each other. Modern collage. Valentines day banner. Healthcare medical concept. Healthy lifestyle.
Cardiovascular disease
Lilly’s RNA Silencer Lowers Key Cardiovascular Biomarker by Almost 94%
March 31, 2025
 · 
2 min read
 · 
Tristan Manalac
Success roadmap journey, milestone or career path achievement, route or pathway to achieve goals, accomplishment, assessment or way to success, businessman look at achievement milestone to success.
GLP-1
Novo Paints Murky Cardio Picture for Semaglutide Franchise
March 31, 2025
 · 
2 min read
 · 
Tristan Manalac